MSF Challenges Pfizer Patent Application For Pneumonia Vaccine In India
Today, Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent opposition against Pfizer’s vaccine for pneumonia in India.
Original news and analysis on international IP policy
Today, Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent opposition against Pfizer’s vaccine for pneumonia in India.

The World Health Organization has provided a list of suggestions to the United Nations Secretary General’s High-Level Panel on Access to Medicines, highlighting WHO activities in this area and making suggestions on areas the WHO has not yet been able to complete. It also describes several new proposals by WHO, including a global “fair pricing forum,” a pooled health product R&D fund, and a global antibiotic research and development facility.

The United States National Institutes of Health’s decision to consider granting an exclusive licence on patents for a newly government-developed vaccine to Sanofi has prompted a strong reaction from civil society warning against potential high prices and requesting transparency in the process.
International experts convened by the World Health Organization this week on the Zika virus said vaccine development is a priority for the future but the most pressing need is to get diagnostic and prevention tools. Over 60 groups are hard at work on experimental products, according to the WHO, while a system of incentives to share virus samples is being considered.

NEW DELHI -- Are patient groups, health activists and manufacturers of low-cost generic drugs always on the same page? Do India’s generic companies think alike? The short answer: not necessarily, though their interests have overlapped on many occasions.
The United Nations Secretary General’s High-Level Panel on Access to Medicines is holding a global dialogue this month, attended by governments, civil society, industry and academia, to discuss potential solutions to promote innovation and at the same time increase access to medicines. The first public dialogue session is this week, on 10 March in London.

The World Health Organization said today that evidence of the relationship between the Zika virus and neonatal malformations and neurological disorders is growing stronger. The Emergency Committee set up by the WHO at a gathering today issued advice to the WHO director general, including warning pregnant women to avoid travelling to Zika infected countries. Meanwhile, discussions are ongoing on the sharing of the samples of the virus, and on the question of benefit-sharing. And a call was made for research and development to intensify.

NAIROBI, Kenya -- Experts and activists are raising concern over the lack of proper intellectual property laws in South Sudan, as the world’s newest nation’s admission into the East Africa Community (EAC) spurs anticipation of increased investment.
The findings, conclusions and preliminary recommendations of a European Commission initiative on the conservation and sustainable use of genetic diversity are to be presented in June, the Commission has announced.

Discussions on the worth of intellectual property for innovation and development have been a recurring agenda item during recent meetings of the World Trade Organization committee on intellectual property. This week, education and how it can raise awareness of IP was discussed with WTO members presenting their national experiences, and some developing countries warning against colluding IP and innovation.
The United Nations High Commissioner for Human Rights, Zeid Ra'ad Al Hussein, today issued a statement urged United States law enforcement authorities to exercise caution in their legal fight against Apple computer company, saying it could have "extremely damaging implications for the human rights of many millions of people, including their physical and financial security."
The World Health Organization has announced it will hold a closed-door, three-day consultation with key stakeholders next week in Geneva to discuss the current status of clinical research into the Zika virus.